CCND1 and glioma: Naringenin supplementation for 1 month can reduce lipid peroxidation and decrease the expression of PKC, NF-κB, cyclin D1(CCND1) and cyclin-dependent kinase 4 (CDK4), thereby inhibiting the proliferation of glioma cells in mouse models (27).